These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16809405)

  • 1. Genetic diagnosis and testing in clinical practice.
    McPherson E
    Clin Med Res; 2006 Jun; 4(2):123-9. PubMed ID: 16809405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
    Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW
    JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic counseling for nonsyndromic pancreatitis.
    Fink EN; Kant JA; Whitcomb DC
    Gastroenterol Clin North Am; 2007 Jun; 36(2):325-33, ix. PubMed ID: 17533082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Counseling the at risk patient in the BRCA1 and BRCA2 Era.
    Barnes-Kedar IM; Plon SE
    Obstet Gynecol Clin North Am; 2002 Jun; 29(2):341-66, vii. PubMed ID: 12108833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic counseling and cascade genetic testing in Lynch syndrome.
    Hampel H
    Fam Cancer; 2016 Jul; 15(3):423-7. PubMed ID: 26969309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic testing and genetic counseling in cardiovascular genetic medicine: overview and preliminary recommendations.
    Cowan J; Morales A; Dagua J; Hershberger RE
    Congest Heart Fail; 2008; 14(2):97-105. PubMed ID: 18401220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predictive genetic testing for hereditary breast cancer and hereditary nonpolyposis colorectal cancer].
    Heyll U; Slany E
    Versicherungsmedizin; 2007 Sep; 59(3):129-35. PubMed ID: 17912887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical indications for genetic testing in familial sudden cardiac death syndromes: an HRUK position statement.
    Heart Rhythm UK Familial Sudden Death Syndromes Statement Development Group
    Heart; 2008 Apr; 94(4):502-7. PubMed ID: 17664186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.
    J Clin Oncol; 1996 May; 14(5):1730-6; discussion 1737-40. PubMed ID: 8622094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic testing for paediatric neurological disorders.
    Valente EM; Ferraris A; Dallapiccola B
    Lancet Neurol; 2008 Dec; 7(12):1113-26. PubMed ID: 19007736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics and clinical practice in rheumatology.
    Cornélis F
    Joint Bone Spine; 2003 Dec; 70(6):458-64. PubMed ID: 14667553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Personal Utility of Genetic Risk Testing.
    David SP; Palaniappan L
    Am Fam Physician; 2018 May; 97(9):600-602. PubMed ID: 29763257
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic testing for disease susceptibilities: consequences for genetic counseling.
    Pagon RA
    Trends Mol Med; 2002 Jun; 8(6):306-7. PubMed ID: 12067618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO.
    Euhus DM; Smith KC; Robinson L; Stucky A; Olopade OI; Cummings S; Garber JE; Chittenden A; Mills GB; Rieger P; Esserman L; Crawford B; Hughes KS; Roche CA; Ganz PA; Seldon J; Fabian CJ; Klemp J; Tomlinson G
    J Natl Cancer Inst; 2002 Jun; 94(11):844-51. PubMed ID: 12048272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline BRCA1/2 testing practices in ovarian cancer: Current state and opportunities for new directions.
    Lheureux S; Karakasis K; Harter P; Scott C; Bacon M; Bryce J; Le Fur N; Pujade-Lauraine E; Oza AM
    Gynecol Oncol; 2016 Jan; 140(1):90-4. PubMed ID: 26475959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility and limitations of genetic testing and information.
    Bradley AN
    Nurs Stand; 2005 Oct 12-18; 20(5):52-5. PubMed ID: 16255487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic counseling program in familial breast cancer: analysis of its effectiveness, cost and cost-effectiveness ratio.
    Balmaña J; Sanz J; Bonfill X; Casado A; Rué M; Gich I; Díez O; Sabaté JM; Baiget M; Alonso MC
    Int J Cancer; 2004 Nov; 112(4):647-52. PubMed ID: 15382046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families.
    Donenberg T; George S; Ali J; Bravo G; Hernandez K; Sookar N; Ashing KT; Narod SA; Akbari MR; Hurley J
    Breast Cancer Res Treat; 2019 Apr; 174(2):469-477. PubMed ID: 30515680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.